Brind.
  1. Health Canada regulates the medical cannabis market access and supply.

Canopy Growth to Supply Medical Cannabis Strains to UK Market

2 reports, 1 independent Updated Sep 22
No new developments lately
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Canopy Growth announced it will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom. The products will be supplied to GROW Group U.K. Ltd. and commercialized in the UK under Canopy Growth’s global Spectrum Therapeutics medical brand. This move expands the company's international cannabis business into another European market.

From recorder.ca

Why it matters

Some supportBrind's analysis of the reports

The supply leverages Canopy Growth's established EU GMP supply capability. This initial launch introduces the company's portfolio into the UK market, building on its existing European medical cannabis business.

Health Canada regulates the medical cannabis market access and supply.

From recorder.ca

Who's involved

  • U.K.Target market for the distribution of the medical cannabis products.
  • OntarioLocation of the cultivation facility utilized for the production of the strains.
  • EuropeGeographic region where the company is expanding its medical cannabis business.

Keep exploring

Part of

Health Canada regulates the medical cannabis market access and supply. All 2 developments

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story